AZmed Secures €5 Million in Series A
AZmed, a Paris, France-based European MedTech startup, has secured €15 million in Series A funding.
AZmed, a Paris, France-based European MedTech startup, has secured €15 million in Series A funding.
SaaS Investors
The round includes investors such as Maison Worms, Techstars, and Teampact Ventures.
AZmed Use of Funds
The company will use the funding to accelerate the development of AZmed's AI-driven medical imaging solutions, aiming to streamline radiologists' workflows and enhance patient care. This funding will fuel AZmed's expansion globally, doubling its workforce and intensifying R&D efforts over the next 18 months.
About AZmed
AZmed was founded in 2018 with one aim: optimizing physicians' workflow and augmenting them with artificial intelligence. AZmed has developed Rayvolve, an AI software that detects bone lesions on standard radiographs. Rayvolve is a SaaS product and is integrated into the radiologist's workflow. AZmed's CE-marked AI software for fracture detection on X-rays, followed by FDA clearance in 2022, is already deployed in over 1,000 healthcare facilities across 40 countries.
Funding Details
Company: AZmed
Raised: €15.0M
Round: Series A
Funding Month: February 2024
Investors: Maison Worms, Techstars, and Teampact Ventures
Company Website: https://azmed.co/
Software Category: Medical Imaging
